CompaniesVabiotech

Vabiotech

active
Hanoi, Vietnam
Founded 2000
Website
About

Vaccines

Areas of Focus

Categories

VaccineAsia
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

2

As Collaborator

4

Total Enrollment

1,213

By Phase

NA: 2PHASE4: 3PHASE2: 1

By Status

COMPLETED: 4UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT00908622
Hover over trial bars to see details

Recent Trials

NCT05140720Lead Sponsor
Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age
NAUnknown
300 participants
Started: Jan 25, 2022 · Completed: Jun 1, 2022
NCT04384016Collaborator
Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old
PHASE4Completed
201 participants
Started: Apr 17, 2021 · Completed: Apr 19, 2022
NCT05937113Collaborator
Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally
PHASE4Completed
220 participants
Started: Jun 13, 2020 · Completed: Oct 30, 2020
NCT03659201Collaborator
Efficacy and Safety of Neosil on Chronic Effluvium
PHASE4Completed
232 participants
Started: Sep 3, 2018 · Completed: Mar 30, 2020
NCT03931239Lead Sponsor
The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks
NACompleted
222 participants
Started: Mar 1, 2018 · Completed: Jul 30, 2018
View all 6 trials →
Locations (1)
Headquarters
Hanoi, Vietnam
Map

Loading map...